The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
Open accessAbstract
Minnelide prevents tumor formation, causes tumor regression, and increases survival in multiple models of pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · cited 2×
“However, gemcitabine has been shown to be ineffective in the immunocompetent KPC model (30, 31).”
BackgroundTumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Von Hoff, D. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 601
Preoperative Staging and Assessment of Resectability of Pancreatic Cancer
Warshaw, A. L. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410140108018 · Cited by 471
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 380
Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase
Yunis, A. A., Arimura, G. K., & Russin, D. J. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190118 · Cited by 373
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 317
Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70
Phillips, P. A., Dudeja, V., McCarroll, J. A., Borja-Cacho, D., Dawra, R. K., Grizzle, W. E., Vickers, S. M., & Saluja, A. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1077 · Cited by 303
Self-citationGenetically Engineered Models Have Advantages over Xenografts for Preclinical Studies
Becher, O. J., & Holland, E. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3827 · Cited by 243
Heat Shock Protein 70 Increases Tumorigenicity and Inhibits Apoptosis in Pancreatic Adenocarcinoma
Aghdassi, A., Phillips, P., Dudeja, V., Dhaulakhandi, D., Sharif, R., Dawra, R., Lerch, M. M., & Saluja, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1567 · Cited by 230
Self-citationPancreatic cancer microenvironment
Kleeff, J., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, J. M., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 225
Bisht, S., Mizuma, M., Feldmann, G., Ottenhof, N. A., Hong, S.-M., Pramanik, D., Chenna, V., Karikari, C., Sharma, R., Goggins, M. G., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0172 · Cited by 216
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
Singh, M., Lima, A., Molina, R., Hamilton, P., Clermont, A. C., Devasthali, V., Thompson, J. D., Cheng, J. H., Bou Reslan, H., Ho, C. C. K., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1640 · Cited by 215
Burris, H. A., & Storniolo, A. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00324-3 · Cited by 199
The Role of the Tumor Microenvironment in the Progression of Pancreatic Cancer
Farrow, B., Albo, D., & Berger, D. H. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.12.757 · Cited by 186
Chen, W. H., Horoszewicz, J. S., Leong, S. S., Shimano, T., Penetrante, R., Sanders, W. H., Berjian, R., Douglass, H. O., Martin, E. W., & Chu, T. M. (1982) · In Vitro · doi:10.1007/bf02796382 · Cited by 162
Tumor microenvironment and progression of pancreatic cancer.
Erkan, M., Reiser–Erkan, C., Michalski, C. W., & Kleeff, J. H. (2010) · PubMed · Cited by 136
Mazur, P. K., & Siveke, J. T. (2011) · Gut · doi:10.1136/gutjnl-2011-300756 · Cited by 118
Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
Dineen, S. P., Roland, C. L., Greer, R. M., Carbon, J. G., Toombs, J. E., Gupta, P. K., Bardeesy, N. M., Sun, H., Williams, N. S., Minna, J. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3892 · Cited by 98
Antonoff, M. B., Chugh, R., Borja–Cacho, D., Dudeja, V., Clawson, K. A., Skube, S. J., Sorenson, B. S., Saltzman, D. A., Vickers, S. M., & Saluja, A. K. (2009) · Surgery · doi:10.1016/j.surg.2009.04.023 · Cited by 88
Self-citationErkan, M., Reiser–Erkan, C., Michalski, C. W., Kong, B., Esposito, I., Frieß, H., & Kleeff, J. H. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218921 · Cited by 88
Sun, F., Tohgo, A., Bouvet, M., Yagi, S., Nassirpour, R., Moossa, A. R., & Hoffman, R. M. (2003) · PubMed · Cited by 57
Triptolide and TRAIL Combination Enhances Apoptosis in Cholangiocarcinoma
Clawson, K. A., Borja–Cacho, D., Antonoff, M. B., Saluja, A. K., & Vickers, S. M. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.03.067 · Cited by 54
Self-citationIwamura, T., TANIGUCHI, S., Kitamura, N., Yamanari, H., KOJIMA, A., Hidaka, K., Setoguchi, T., & Katsuki, T. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb01030.x · Cited by 47
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
Zhao, M., Tominaga, Y., Ohuchida, K., Mizumoto, K., Cui, L., Kozono, S., Fujita, H., Maeyama, R., Toma, H., & Tanaka, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02113.x · Cited by 33
Drucker, B. J., Marincola, F. M., Siao, D. Y., Donlon, T. A., Bangs, C. D., & Holder, W. D. (1988) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624187 · Cited by 31
Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer
Damaraju, V. L., Bouffard, D. Y., Wong, C. K. W., Clarke, M. L., Mackey, J. R., Leblond‐Larouche, L., Cass, C. E., Grey, M., & Gourdeau, H. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-121 · Cited by 31
DeRosier, L. C., Huang, Z., Sellers, J. C., Buchsbaum, D. J., & Vickers, S. M. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.007 · Cited by 16
Self-citation
Cited by
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Triptolide: Progress on research in pharmacodynamics and toxicology
Li, X.-J., Jiang, Z.-Z., & Zhang, L.-Y. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.06.006 · Cited by 378
“…for 48 days in vivo, 200 nM for 48 h in vitro), minnelide (0.1– 0.6 mg/kg for 48 days in vivo, 100–200 nM for 48 h in vitro), was verified as a potential anti-tumor agent against pancreatic cancer both in vitro (Panc-1,S2-013 and S2-VP10) and in vivo (female athymic mice) (Chugh et al., 2012).”
BackgroundInfluentialWitzel, S., Hashmi, A. S. K., & Xie, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00841 · Cited by 378
Chen, S.-R., Dai, Y., Zhao, J., Lin, L., Wang, Y., & Wang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00104 · Cited by 326
Exploiting replicative stress to treat cancer
Dobbelstein, M., & Sørensen, C. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4553 · Cited by 302
Metadata
- Authors
- Chugh, R., Sangwan, V., Patil, S. P., Dudeja, V., Dawra, R. K., Banerjee, S., Schumacher, R. J., Blazar, B. R., Georg, G. I., Vickers, S. M., & Saluja, A. K.
- Venue
- Science Translational Medicine
- Published
- 2012-10-17
- Volume
- 4
- Issue
- 156
- Pages
- 156ra139-156ra139
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2155671268
- Cited by
- 268
- References
- 34
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.